Enanta Pharmaceuticals ENTA Stock Consolidating at 1379 Next Move Ahead 20260520 Marvell Technology Could Its Data Infrastructure Focus Unlock LongTerm Value Dollar Retreats as Geopolitical Risks and Fed Policy Dominate Trader Focus Lantern Pharma LTRN Q1 2026 Earnings EPS 030 Beats Estimates Vodafone Idea Shares Surge 43 in One Month Whats Driving the Rally and Key Risks Ahead Sensex Rejig Trent May Face Replacement in Upcoming Index Reshuffle Two Stocks Emerge as Leading Contenders